床旁肌超声与血浆单核细胞趋化蛋白-1对脓毒症患者ICU获得性衰弱的诊断准确性
前瞻性观察研究纳入河南省人民医院ICU 2021年4月至2021年10月收治的99例脓毒症患者,按MRC总分<48分(连续2次、间隔24小时)分为ICU-AW组68例与非ICU-AW组31例,于入ICU第1、4、7天行床旁超声测量RF-MLT、RF-CSA、VI-MLT并用ELISA测血浆MCP-1。二元Logistic回归显示APACHE II评分与脓毒症休克是ICU-AW的危险因素,OR分别为1.310(1.138-1.509)和0.232(0.072-0.746),均P<0.05。第7天RF-MLT诊断ICU-AW的AUC为0.688(95%CI 0.526-0.849),切点0.41 cm时敏感度66.7%、特异度68.4%;第1、4、7天血浆MCP-1的AUC分别为0.732(0.629-0.836)、0.865(0.777-0.953)、0.891(0.795-0.986)。结论认为第7天肌量参数与血浆MCP-1对脓毒症患者ICU-AW有一定诊断价值。
要点
- 99例脓毒症患者中ICU-AW组68例、非ICU-AW组31例;MRC总分<48分连续2次(间隔24小时)即判为ICU-AW。
- 第7天血浆MCP-1诊断ICU-AW的AUC为0.891(95%CI 0.795-0.986),切点239.5 ng/L时敏感度82.4%、特异度86.2%。
- 第7天RF-MLT诊断ICU-AW的AUC为0.688(95%CI 0.526-0.849),切点0.41 cm时敏感度66.7%、特异度68.4%。
- 二元Logistic回归显示APACHE II评分(OR 1.310,95%CI 1.138-1.509)与脓毒症休克(OR 0.232,95%CI 0.072-0.746)是ICU-AW的危险因素,均P<0.05。
- 非ICU-AW组第7天RF-MLT更小[0.32(0.22,0.47)cm vs. 0.45(0.34,0.63)cm,P<0.05],7天RF-CSA萎缩率更高[25.85%(10.37%,34.28%)vs. 11.65%(2.28%,22.41%),P<0.05]。
适用人群与场景
- 2021年4月至2021年10月河南省人民医院ICU收治的脓毒症患者,共纳入99例。
诊断标准与关键阈值
- 每日用医学研究委员会(MRC)评分评估至出ICU,总分<48分且连续2次、间隔24小时者判为ICU-AW组(68例),总分≥48分者为非ICU-AW组(31例)。
处置流程与药物剂量
- 入ICU第1、4、7天用超声测量股直肌肌层厚度(RF-MLT)、股直肌横截面积(RF-CSA)和股中间肌肌层厚度(VI-MLT),同时采集血浆用酶联免疫吸附试验(ELISA)测MCP-1浓度。
研究设计与关键结果
- 前瞻性观察研究纳入99例脓毒症患者,ICU-AW组68例、非ICU-AW组31例;非ICU-AW组倾向更年轻、SOFA评分更低、APACHE II评分更低、脓毒症休克比例更低、血乳酸更低、GCS更高。
- 二元Logistic回归显示APACHE II评分和脓毒症休克是脓毒症患者ICU-AW的危险因素,OR(95%CI)分别为1.310(1.138-1.509)和0.232(0.072-0.746),均P<0.05。
- RF-MLT、RF-CSA和VI-MLT在入ICU第1、4、7天随时间下降;非ICU-AW组第7天RF-MLT小于ICU-AW组[0.32(0.22,0.47)cm vs. 0.45(0.34,0.63)cm,P<0.05],7天RF-CSA萎缩率高于ICU-AW组[25.85%(10.37%,34.28%)vs. 11.65%(2.28%,22.41%),P<0.05]。
- 第7天RF-MLT诊断ICU-AW的AUC为0.688(95%CI 0.526-0.849),切点0.41 cm时敏感度66.7%、特异度68.4%。
- ICU-AW组血浆MCP-1在第1、4、7天均显著高于非ICU-AW组;第1、4、7天MCP-1诊断ICU-AW的AUC(95%CI)分别为0.732(0.629-0.836)、0.865(0.777-0.953)、0.891(0.795-0.986)。
- MCP-1切点第1天206.3 ng/L、第4天410.9 ng/L、第7天239.5 ng/L时,敏感度分别为87.1%、64.0%、82.4%,特异度分别为54.4%、96.1%、86.2%。
证据类型、等级与局限
- 证据类型:前瞻性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为入ICU第7天床旁超声肌量参数和血浆MCP-1水平对脓毒症患者ICU-AW有一定诊断价值。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the diagnostic accuracy of muscle ultrasound and plasma monocyte chemoattractant protein-1 (MCP-1) for ICU-acquired weakness (ICU-AW) in patients with sepsis.
METHODS: A prospective observational study was conducted. Patients with sepsis admitted to the intensive care unit (ICU) of Henan Provincial People's Hospital from April 2021 to October 2021 were enrolled. The demographic data were collected. The enrolled patients were evaluated with Medical Research Council (MRC) score every day until discharged from ICU. During this period, patients with total MRC score < 48 (for two consecutive times and a time interval of 24 hours) were divided into ICU-AW group, those with total MRC score ≥ 48 were served as non-ICU-AW group. On the 1st, 4th and 7th day following admission into ICU, ultrasound was used to measure the muscle linear thickness of the rectus femoris (RF-MLT), the cross sectional area of the rectus femoris (RF-CSA) and the muscle linear thickness of the vastus intermedius muscle (VI-MLT). And meanwhile, the plasmas samples of patients were collected to measure MCP-1 concentration by enzyme-linked immunosorbent assay (ELISA). The difference of each index was compared between the ICU-AW group and the non-ICU-AW group. The risk factors of ICU-AW in patients with sepsis were analyzed by binary Logistic regression. Besides, receiver operator characteristic curve (ROC curve) was plotted, the diagnostic value of ultrasound parameters and plasma MCP-1 level for ICU-AW in patients with sepsis was analyzed.
RESULTS: A total of 99 septic patients were enrolled, with 68 patients in the ICU-AW group and 31 patients in the non-ICU-AW group. Compared with the patients in the ICU-AW group, the patients in the non-ICU-AW group tended to be older, and had higher sequential organ failure assessment (SOFA) score, higher acute physiology and chronic health evaluation II (APACHE II) score, higher rates of septic shock, higher blood lactic acid and lower Glasgow coma score (GCS). Binary Logistic regression analysis showed that APACHE II score and septic shock were the risk factors of ICU-AW for septic patients [odds ratio (OR) and 95% confidence interval (95%CI) were 1.310 (1.138-1.509) and 0.232 (0.072-0.746), respectively, both P < 0.05]. The RF-MLT, RF-CSA and VI-MLT on the 1st, 4th and 7th ICU day was falling over time. Compared with the patients in the ICU-AW group, the patients in the non-ICU-AW group had smaller RF-MLT on the 7th day [cm: 0.32 (0.22, 0.47) vs. 0.45 (0.34, 0.63), P < 0.05] and higher 7-day RF-CSA atrophy rate [25.85% (10.37%, 34.28%) vs. 11.65% (2.28%, 22.41%), P < 0.05]. According to ROC curve analysis, 7-day RF-MLT had diagnostic value for ICU-AW of septic patients. Area under ROC curve (AUC) was 0.688 (95%CI was 0.526-0.849); when the cut-off value was 0.41 cm, the sensitivity and the specificity were 66.7% and 68.4%. The levels of plasma MCP-1 in the ICU-AW group were significantly higher than those in the non-ICU-AW group on the 1st, 4th and 7th day. ROC curve analysis showed that the plasma MCP-1 levels on the 1st, 4th and 7th day played a significant role to diagnose ICU-AW for septic patients, the AUC and 95%CI were 0.732 (0.629-0.836), 0.865 (0.777-0.953), 0.891 (0.795-0.986), respectively. When the cut-off values were 206.3, 410.9, 239.5 ng/L, the sensitivity was 87.1%, 64.0%, 82.4%, and the specificity was 54.4%, 96.1%, 86.2%, respectively.
CONCLUSIONS: The muscle mass parameters on the 7th day of bedside ultrasound and plasma MCP-1 levels had certain diagnostic values for ICU-AW in patients with sepsis.
参考来源
- Ding M, Ren S, Dong X, et al. [Diagnostic accuracy of muscle ultrasound and plasma monocyte chemoattractant protein-1 for ICU-acquired weakness in patients with sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 35307054. doi:10.3760/cma.j.cn121430-20211021-01531
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。